⌘K
Loading ticker…
Sarepta Therapeutics,, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Sarepta Therapeutics,, Inc. Common Stock (SRPT) has a 3-month relative strength percentile of 15 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 43. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.1%, relative volume 6.69×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
15 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
SRPT is in a stage 4 downtrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -8.0% / -14.4%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
SRPT is held by 11 ETFs as of Mar 2026. Top owner: IJR at 0.15% weight, $137M notional. Top 3 carry $273M.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.15% | $137M |
| VTIVanguard Total Stock Market ETF | 0.00% | $70M |
| XBIState Street SPDR S&P Biotech ETF | 0.89% | $67M |
| VBVanguard Small Cap ETF | 0.03% | $50M |
| VBKVanguard Small-Cap Growth ETF | 0.07% | $28M |
| VXFVanguard Extended Market ETF | 0.03% | $25M |
| IWRiShares Russell Midcap ETF | 0.02% | $8M |
| IWFiShares Russell 1000 Growth ETF | 0.01% | $7M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $3M |
| IWBiShares Russell 1000 ETF | 0.00% | $1M |
Showing 10 of 11 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SRPT Jan avg: 1.97% median: -4.52% win: 25% σ: 14.33% n: 4 2022-04-12 → 2026-05-29 | SRPT Feb avg: -4.63% median: -4.20% win: 25% σ: 10.38% n: 4 2022-04-12 → 2026-05-29 | SRPT Mar avg: 0.92% median: 7.04% win: 75% σ: 29.84% n: 4 2022-04-12 → 2026-05-29 | SRPT Apr avg: -6.72% median: -4.04% win: 0% σ: 5.54% n: 5 2022-04-12 → 2026-05-29 | SRPT May avg: -10.05% median: 0.68% win: 60% σ: 17.95% n: 5 2022-04-12 → 2026-05-29 | SRPT Jun avg: -9.31% median: -2.20% win: 50% σ: 32.44% n: 4 2022-04-12 → 2026-05-29 (current) | SRPT Jul avg: 1.17% median: -4.67% win: 25% σ: 15.43% n: 4 2022-04-12 → 2026-05-29 | SRPT Aug avg: 8.91% median: 11.24% win: 75% σ: 9.47% n: 4 2022-04-12 → 2026-05-29 | SRPT Sep avg: -0.23% median: 0.62% win: 75% σ: 5.77% n: 4 2022-04-12 → 2026-05-29 | SRPT Oct avg: -3.96% median: 2.02% win: 75% σ: 29.04% n: 4 2022-04-12 → 2026-05-29 | SRPT Nov avg: 5.79% median: 6.77% win: 75% σ: 13.08% n: 4 2022-04-12 → 2026-05-29 | SRPT Dec avg: 4.05% median: 3.18% win: 75% σ: 11.41% n: 4 2022-04-12 → 2026-05-29 |